Skip to main content
. 2018 Feb 21;18(2):1–160.

Table 32:

Estimated Annual Per-Patient Costs (All Direct Medical Costs) of Continuous Glucose Monitoring in Ontario

Intervention Technology Year 1, $ Year 2, $ Year 3, $ Year 4, $ Year 5, $
Comparators
SMBG + multiple daily injections 3,677 4,039 4,277 4,431 4,515
SMBG + insulin pump Animas Vibe 6,817 7,175 7,365 7,450 7,458
Interventions
CGM + multiple daily injections Dexcom G4/G5 9,342a 9,693a 9,810a 9,830a 9,775a
CGM + insulin pump Integrated 11,673b 12,075b 12,126b 12,090b 11,980b
SAP with LGS MiniMed Veo 9,211 9,531 9,673 9,701 9,649
SAP or SAP with LGS 10% SAP; 90% SAP with LGS 9,457 9,785 9,918 9,940 9,882
Average for CGM devices 40% CGM + multiple daily injections; 60% CGM + SAP 9,411 9,748 9,875 9,896 9,839

Abbreviations: CGM, continuous glucose monitoring; LGS, low-glucose suspend [feature]; SAP, sensor-augmented pump; SMBG, self-monitoring of blood glucose.

a

Average cost of Dexcom G4 Platinum and Dexcom G5 Mobile.

b

Average cost of Dexcom G4 Platinum + Animas Vibe and Dexcom G5 Mobile + Animas Vibe.